Wheatley Spence

Wheatley Spence is an accomplished professional in regulatory affairs, currently serving as the Head of Global Regulatory Affairs at Tisento Therapeutics since November 2023. Previously, Wheatley held the position of Senior Director at EQRx from September 2022 to January 2024 and at Jazz Pharmaceuticals from June 2016 to September 2022. Prior experience includes roles as Associate Director and Director in Global Regulatory Strategy at Merck, starting from March 2001 until June 2015. Wheatley Spence holds a Master of Science in Health Policy from the University of the Sciences in Philadelphia, obtained in January 2012, and a Bachelor of Science degree in Chemistry, Biochemistry, and Healthcare Administration from La Salle University, completed in January 2000.